Suppr超能文献

应用种族和民族推断及队列平衡技术实现公平临床试验招募的真实世界应用。

Real-world Application of Racial and Ethnic Imputation and Cohort Balancing Techniques to Deliver Equitable Clinical Trial Recruitment.

机构信息

Clinical Evidence Development, Aetna Medical Affairs, CVS Health, Wellesley, MA, US.

Clinical Trial Services, CVS Health, Woonsocket, RI, US.

出版信息

AMIA Annu Symp Proc. 2024 Jan 11;2023:319-328. eCollection 2023.

Abstract

Enhancing diversity and inclusion in clinical trial recruitment, especially for historically marginalized populations including Black, Indigenous, and People of Color individuals, is essential. This practice ensures that generalizable trial results are achieved to deliver safe, effective, and equitable health and healthcare. However, recruitment is limited by two inextricably linked barriers - the inability to recruit and retain enough trial participants, and the lack of diversity amongst trial populations whereby racial and ethnic groups are underrepresented when compared to national composition. To overcome these barriers, this study describes and evaluates a framework that combines 1) probabilistic and machine learning models to accurately impute missing race and ethnicity fields in real-world data including medical and pharmacy claims for the identification of eligible trial participants, 2) randomized controlled trial experimentation to deliver an optimal patient outreach strategy, and 3) stratified sampling techniques to effectively balance cohorts to continuously improve engagement and recruitment metrics.

摘要

在临床试验招募中增强多样性和包容性,特别是对于历史上被边缘化的人群,包括黑人和少数族裔,这是至关重要的。这种做法确保了可推广的试验结果,以提供安全、有效和公平的健康和医疗保健。然而,招募受到两个不可分割的障碍的限制 - 无法招募和留住足够的试验参与者,以及试验人群中缺乏多样性,与全国构成相比,种族和族裔群体代表性不足。为了克服这些障碍,本研究描述并评估了一个框架,该框架结合了 1)概率和机器学习模型,以准确推断真实世界数据中缺失的种族和族裔字段,包括医疗和药房索赔,以确定合格的试验参与者,2)随机对照试验实验,以提供最佳的患者外展策略,以及 3)分层抽样技术,以有效地平衡队列,不断提高参与度和招募指标。

相似文献

4
Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial.
Clin Trials. 2011 Apr;8(2):214-23. doi: 10.1177/1740774510396742. Epub 2011 Jan 17.
5
Is Our Science Representative? A Systematic Review of Racial and Ethnic Diversity in Orthopaedic Clinical Trials from 2000 to 2020.
Clin Orthop Relat Res. 2022 May 1;480(5):848-858. doi: 10.1097/CORR.0000000000002050. Epub 2021 Dec 2.

本文引用的文献

1
The FDA Initiative to Assure Racial and Ethnic Diversity in Clinical Trials.
J Am Board Fam Med. 2023 Apr 3;36(2):366-368. doi: 10.3122/jabfm.2022.220290R1. Epub 2023 Feb 17.
2
Enhancing Diversity and Inclusion in Clinical Trials.
Clin Pharmacol Ther. 2023 Mar;113(3):489-499. doi: 10.1002/cpt.2819. Epub 2023 Jan 11.
3
Promoting Clinical Trial Diversity: A Highlight of Select US FDA Initiatives.
Clin Pharmacol Ther. 2023 Mar;113(3):528-535. doi: 10.1002/cpt.2822. Epub 2022 Dec 30.
4
Race/ethnicity reporting and representation in US clinical trials: a cohort study.
Lancet Reg Health Am. 2022 Jul;11. doi: 10.1016/j.lana.2022.100252. Epub 2022 Apr 10.
5
Inclusion of Under-Represented Racial and Ethnic Groups in Cardiovascular Clinical Trials.
Heart Lung Circ. 2022 Sep;31(9):1263-1268. doi: 10.1016/j.hlc.2022.06.668. Epub 2022 Jul 16.
6
Recruitment of Black Adults into Cardiovascular Disease Trials.
J Am Heart Assoc. 2021 Sep 7;10(17):e021108. doi: 10.1161/JAHA.121.021108. Epub 2021 Aug 25.
7
Assessment of the Inclusion of Racial/Ethnic Minority, Female, and Older Individuals in Vaccine Clinical Trials.
JAMA Netw Open. 2021 Feb 1;4(2):e2037640. doi: 10.1001/jamanetworkopen.2020.37640.
8
Contemporary use of real-world data for clinical trial conduct in the United States: a scoping review.
J Am Med Inform Assoc. 2021 Jan 15;28(1):144-154. doi: 10.1093/jamia/ocaa224.
9
Digitizing clinical trials.
NPJ Digit Med. 2020 Jul 31;3:101. doi: 10.1038/s41746-020-0302-y. eCollection 2020.
10
Recruitment and retention of participants in clinical studies: Critical issues and challenges.
Perspect Clin Res. 2020 Apr-Jun;11(2):51-53. doi: 10.4103/picr.PICR_6_20. Epub 2020 May 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验